• Email Page
• Print Page
• Site Map

ARIXTRA has a broad range of
FDA-approved indications

ARIXTRA is approved for the treatment and prophylaxis of venous thromboembolism (VTE). Learn more about ARIXTRA’s approved indications below.

• Treatment of deep vein thrombosis (DVT)^*, including outpatient
• Treatment of pulmonary embolism (PE)^*, including outpatient^†
• VTE prophylaxis after major orthopedic surgery^‡
• Extended VTE prophylaxis after hip fracture surgery
• VTE prophylaxis after abdominal surgery^§

^*When administered in conjunction with warfarin.
^†When initial therapy is started in the hospital.
^‡Knee replacement, hip replacement and hip fracture surgery.
^§ For patients at risk for thromboembolic complications.

• Home
• Prescribing Information
• Indications
• Dosing & Administration
• How ARIXTRA Works


• Important Safety Information
• Health Care Professional Resources
• Support & Reimbursement
• References
• Site Map

Please see Important Safety Information and complete Prescribing Information, including BOXED WARNING
regarding epidural and spinal hematomas.